IP Library Granted Patent US 8,853,429
Granted Patent B2
US 8,853,429 · App. 13/951,650 · Granted Oct 7, 2014

Process and intermediate compounds useful in the preparation of statins

Inventors: David John Moody (Fife, GB); Jonathan William Wiffen (County Down, GB)
Assignee: Redx Pharma Limited
C07B41/08C07D405/06C07D257/04C07D309/30C07D209/24C07C51/09C07D309/10C07D215/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,853,429
App. No.
13/951,650
Granted
Oct 7, 2014
Kind
B2
Abstract

There is provides a process for the preparation of a compound of formula ( 7 ): wherein R is an optionally substituted hydrocarbyl group or an optionally substituted heterocyclic group; provides that R is not a compound of Formula (a): wherein R a represents an alkyl group, such as a C 1-16 alkyl group, and preferably an isopropyl group; R b represents an aryl group, preferably a 4-fluorophenyl group; R c represents hydrogen, a protecting group or an alkyl group, such as a C 1-16 alkyl group, and preferably a methyl group; and Rd represents hydrogen, a protecting group or a SO 2 R e group where R e is an alkyl group, such as a C 1-16 alkyl group, and preferably a methyl group.

Claims (47)

1. A process for the preparation of a compound of formula (7):

wherein

R is a substituted or unsubstituted alkenyl or aryl group or any combination thereof, or a substituted or unsubstituted heterocyclic group;

provided that R is not a compound of Formula (a):

wherein

R a is an alkyl group;

R b is an aryl group;

R c is hydrogen, a protecting group or an alkyl group; and

R d is hydrogen, a protecting group or a SO 2 R e group, where R e is an alkyl group,

which comprises:

a) hydroxylating a compound of formula (1):

wherein Y is a halo group, P 1 is hydrogen or a protecting group, and W is —OP 2 , in which P 2 represents hydrogen or a protecting group, to give a compound of formula (2):

b) oxidizing the compound of formula (2) to provide a compound of formula (3):

wherein W represents —OP 2 or ═O,

c) the process further comprising forming a compound of formula (2) or (3) in which W represents ═O by: oxidizing a compound of formula (2) or (3) wherein P 2 is hydrogen; or deprotecting and oxidizing a compound of formula (2) or (3) wherein P 2 is a protecting group;

d) coupling the compound of formula (3) wherein W represents ═O with a compound of formula (4):

wherein Z is (PR 11 R 12 ) + X − or P(═O)R 11 R 12 , wherein X is an anion and R 11 and R 12 each independently is an alkyl, aryl, alkoxy or aryloxy group, to give a compound of formula (5) wherein W represents ═O:

and

e) subjecting the compound of formula (5) to ring-opening, removal of any P 1 protecting groups, and optionally removing any additional protecting groups to provide a compound of formula (7).

2. The process of claim 1 wherein Y is Cl or Br.

3. The process of claim 1 , wherein R is selected from:

and wherein

R 1 is a hydrogen, a protecting group or a substituted or unsubstituted hydrocarbyl group;

R 2 is a an optionally substituted acyl group;

R 3 is an optionally substituted acyl group;

R 4 is a substituted or unsubstituted hydrocarbyl group;

R 5 is a substituted or unsubstituted hydrocarbyl group;

R 6 is a substituted or unsubstituted hydrocarbyl group;

R 7 is a substituted or unsubstituted hydrocarbyl group;

R 8 is a substituted or unsubstituted hydrocarbyl group, or substituted or unsubstituted heterocyclic group;

R 9 is a substituted or unsubstituted hydrocarbyl group;

R 10 is a substituted or unsubstituted hydrocarbyl group.

4. The process of claim 3 , wherein R 1 is an alkyl group and/or R 2 is an alkanoyl group.

5. The process of claim 4 , wherein R 1 is a C 1-6 alkyl group and/or R 2 is a C 1-8 alkanoyl group.

6. The process of claim 5 , wherein R 2 is a —C(O)CH(Me)CH 2 CH 3 or —C(O)C(Me) 2 CH 2 CH 3 group.

7. The process of claim 3 , wherein R 3 is an alkanoyl group.

8. The process of claim 7 , wherein R 3 is a C 1-8 alkanoyl group.

9. The process of claim 7 , wherein R 3 is a —C(O)CH(Me)CH 2 CH 3 or a —, C(O)C(Me) 2 CH 2 CH 3 group.

10. The process of claim 3 , wherein R 4 is a substituted or unsubstituted aryl group and/or R 5 is a substituted or unsubstituted alkyl group.

11. The process of claim 10 , wherein R 4 is a 4-fluorophenyl group and/or R 5 is a cyclopropyl group.

12. The process of claim 3 , wherein R 6 is a substituted or unsubstituted aryl group and/or R 7 is a substituted or unsubstituted alkyl group.

13. The process of claim 12 , wherein R 6 is a 4-fluorophenyl group and/or R 7 is an isopropyl group.

14. The process of claim 3 , wherein R 8 is a substituted or unsubstituted aryl or a substituted or unsubstituted aromatic heterocyclic group; R 9 is a substituted or unsubstituted aryl group; and/or R 10 is a substituted or unsubstituted aryl group.

15. The process of claim 14 , wherein R 8 is a methyltetrazoyl group; R 9 is a 4-fluorophenyl group; and/or R 10 is a 4-fluorophenyl group.

16. The process of claim 3 , wherein Y is Cl or Br.

17. The process of claim 1 , wherein the process further comprises forming a compound of formula (2) in which W represents ═O by: oxidising a compound of formula (2) when W is OP 2 and P 2 is hydrogen; or deprotecting and oxidising a compound of formula (2) when W is OP 2 and P 2 is a protecting group.

18. The process of claim 1 , wherein the process further comprises forming a compound of formula (3) wherein W represents ═O by: oxidising a compound of formula (3) when W is —OP 2 and P 2 is hydrogen; or deprotecting and oxidising a compound of formula (3) when W is —OP 2 and P 2 is a protecting group.

Assignments (1)
CHANGE OF NAME Recorded Apr 17, 2015
From: REDX PHARMA LIMITED
To: REDX PHARMA PLC
Reel/Frame 035455/0507 →
Priority Claims (1)
GB 0427491.6 · Dec 16, 2004 · national
Continuity (3)
Continuation 13599606 · Aug 30, 2012
Continuation 11721858
Related Publication 20130345429A1 · Dec 26, 2013